Pharmacy technician put “non-narcotic drugs” in oxycodone bottles
Bio SmartBrief notes that the disagreements could sink plans to establish a national system for tracking and tracing pharmaceuticals. A group of drug manufacturers, distributors and pharmacies says tracking drug lots rather than individual packages, as the FDA proposes, would be cheaper and simpler to implement.
A growing number of patient-advocacy groups are playing matchmaker, linking patients to researchers who need them for clinical trials.
Accordingly, drug makers and governments are trying to find ways to stabilize their cost.
Bipartisan federal bill would speed up the approval process for drugs that treat life-threatening diseases
The bill is designed to improve outcomes for patients with fatal diseases such as cancer, AIDS, and Alzheimer’s disease.
Two of the Food and Drug Administration’s advisory panels recommended last week that advisory labels for the drugs, including Actonel and Boniva, include stronger cautionary language. The FDA usually follows such recommendations, but not always, comments the New York Times in its article on the issue.
Already-approved drugs are now being used to combat diseases they weren’t originally intended to combat.
Patients are now being affected by a decline in avaible drugs, as a result, hospital labor costs are on the rise to work around shortages.
Blizzard, a synthetic drug and marketed bath salt, can be dangerous to consumers causing mental derangement and even death.